Protein-Based Nanoparticles as Drug Delivery Systems

被引:345
作者
Hong, Seyoung [1 ]
Choi, Dong Wook [2 ]
Kim, Hong Nam [3 ]
Park, Chun Gwon [4 ,5 ]
Lee, Wonhwa [6 ]
Park, Hee Ho [1 ]
机构
[1] Kangwon Natl Univ, Dept Biotechnol & Bioengn, Chunchon 24341, South Korea
[2] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[3] Korea Inst Sci & Technol KIST, Brain Sci Inst, Ctr BioMicrosyst, Seoul 02792, South Korea
[4] Sungkyunkwan Univ SKKU, SKKU Inst Convergence, Dept Biomed Engn, Suwon 16419, South Korea
[5] Sungkyunkwan Univ, Biomed Inst Convergence SKKU BICS, 2066 Seobu Ro, Suwon 16419, South Korea
[6] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Daejeon 34141, South Korea
基金
新加坡国家研究基金会;
关键词
protein nanoparticle; drug delivery; biocompatible; biodegradable; controlled release; SILK FIBROIN NANOPARTICLES; HUMAN SERUM-ALBUMIN; HIGH-DENSITY-LIPOPROTEIN; CONTROLLED-RELEASE; GLIADIN NANOPARTICLES; PHYSICOCHEMICAL PROPERTIES; TARGETED DELIVERY; HSA-NANOPARTICLES; GENE DELIVERY; CANCER-CELLS;
D O I
10.3390/pharmaceutics12070604
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoparticles have been extensively used as carriers for the delivery of chemicals and biomolecular drugs, such as anticancer drugs and therapeutic proteins. Natural biomolecules, such as proteins, are an attractive alternative to synthetic polymers commonly used in nanoparticle formulation because of their safety. In general, protein nanoparticles offer many advantages, such as biocompatibility and biodegradability. Moreover, the preparation of protein nanoparticles and the corresponding encapsulation process involved mild conditions without the use of toxic chemicals or organic solvents. Protein nanoparticles can be generated using proteins, such as fibroins, albumin, gelatin, gliadine, legumin, 30Kc19, lipoprotein, and ferritin proteins, and are prepared through emulsion, electrospray, and desolvation methods. This review introduces the proteins used and methods used in generating protein nanoparticles and compares the corresponding advantages and disadvantages of each.
引用
收藏
页码:1 / 28
页数:29
相关论文
共 159 条
  • [1] Silk fibroin nanoparticles: Efficient vehicles for the natural antioxidant quercetin
    Abel Lozano-Perez, Antonio
    Correa Rivero, Hector
    Perez Hernandez, Maria del Carmen
    Pagan, Ana
    Montalban, Mercedes G.
    Villora, Gloria
    Luis Cenis, Jose
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 518 (1-2) : 11 - 19
  • [2] Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats
    Abel Lozano-Perez, Antonio
    Rodriguez-Nogales, Alba
    Ortiz-Cullera, Victor
    Algieri, Francesca
    Garrido-Mesa, Jose
    Zorrilla, Pedro
    Elena Rodriguez-Cabezas, M.
    Garrido-Mesa, Natividad
    Utrilla, M. Pilar
    De Matteis, Laura
    Martinez de la Fuente, Jesus
    Luis Cenis, Jose
    Galvez, Julio
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 4507 - 4520
  • [3] Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up A Phase 1b Clinical Trial
    Adams, Sylvia
    Diamond, Jennifer R.
    Hamilton, Erika
    Pohlmann, Paula R.
    Tolaney, Sara M.
    Chang, Ching-Wei
    Zhang, Wei
    Iizuka, Koho
    Foster, Paul G.
    Molinero, Luciana
    Funke, Roel
    Powderly, John
    [J]. JAMA ONCOLOGY, 2019, 5 (03) : 334 - 342
  • [4] [Anonymous], 2010, NANOSCIENCE TECHNOLO
  • [5] Argast Anne., 2004, J GEOSCIENCE ED, V52, P213
  • [6] Drug binding to human serum albumin: Abridged review of results obtained with high-performance liquid chromatography and circular dichroism
    Ascoli, Giorgio A.
    Domenici, Enrico
    Bertucci, Carlo
    [J]. CHIRALITY, 2006, 18 (09) : 667 - 679
  • [7] Azarmi S, 2006, J PHARM PHARM SCI, V9, P124
  • [8] Babaei Z., 2008, J NANOSCI NANOTECHNO, V4, P23
  • [9] Batrakova E.V., 2006, Nanoparticulates as drug carriers, P57, DOI [10.1142/9781860949074_0005, DOI 10.1142/9781860949074_0005]
  • [10] Reversible and covalent binding of drugs to human serum albumin: Methodological approaches and physiological relevance
    Bertucci, C
    Domenici, E
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (15) : 1463 - 1481